Sign Out
KEMOCARB (Carboplatin) is given in doses of 360 mg/m2 body surface area by intravenous infusion over 15 minutes to 1 hour. Doses should not be given more frequently than every 4 weeks and should be reduced in patients at risk of myelosupÂpression. Lower doses may also be given as part of combination regimens.
Preparation of intravenous solution: Immediately before use each vial of KEMOCARB (Carboplatin) should be diluted to concentrations as low as 0.5 mg/ml with 5% Dextrose or 0.9% Sodium Chloride Injection.
